Back to Journals » Neuropsychiatric Disease and Treatment » Volume 18

Efficacy and Safety of Low-Dose Rituximab in Anti-MuSK Myasthenia Gravis Patients: A Retrospective Study

Total article views   HTML views PDF downloads Totals
7,034 Dovepress* 5,470+ 121 5,591
PubMed Central* 1,564 278 1,842
Totals 7,034 399 7,433
*Since 3 May 2022
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed and Google Scholar